Skip to content

Somatic Diseases in Autistic Children

Medical Monitoring and Somatic Diseases in Children Who Suffer From Autism Spectrum Disorder (ASD)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05077020
Acronym
SDA
Enrollment
27
Registered
2021-10-13
Start date
2020-01-01
Completion date
2021-10-01
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autistic Spectrum Disorder, Somatic Disorders

Brief summary

For many reasons, medical monitoring in autistic patients is very difficult. This study is designed to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.

Detailed description

Mean goal : to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier. Secondary goals : * to obtain an objective assessment of the general monitoring in these patients (vaccinations, growth…) * to assess their habits (food, sleep, screen exposition) * to determine, in this monitoring and the habits, vigilance points which will need a specific pediatric consultation.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

\- consultation after psychiatric evaluation

Exclusion criteria

* age \> 18 years * Impossibility to obtain the consent of parents / legal representatives.

Design outcomes

Primary

MeasureTime frameDescription
Determine the prevalence of comorbid diseases1 dayDetermine the prevalence of comorbid diseases

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026